Improve Medical(SZ:300030) Sou Hu Cai Jing·2025-05-06 13:14Core Insights - Yangpu Medical (300030) closed at 6.13 yuan on May 6, 2025, with a 2.85% increase and a trading volume of 76,400 hands, amounting to 46.44 million yuan in transaction value [1] Financial Performance - The company's Q1 2025 report shows a main revenue of 116 million yuan, a year-on-year decrease of 18.15% - The net profit attributable to shareholders was 7.81 million yuan, a year-on-year increase of 344.71% - The non-recurring net profit was 7.30 million yuan, a year-on-year increase of 292.15% - The debt ratio stands at 42.74%, with investment income of 4.35 million yuan and financial expenses of 755,300 yuan - The gross profit margin is reported at 40.19% [2] Market Position - Yangpu Medical's total market value is 1.895 billion yuan, significantly lower than the industry average of 10.293 billion yuan, ranking 111 out of 122 in the medical device sector - The net assets amount to 652 million yuan, with a ranking of 113 out of 122 - The net profit is 7.81 million yuan, ranking 86 out of 122 - The price-to-earnings ratio (P/E) is 60.68, compared to the industry average of 52.22, ranking 69 out of 122 - The price-to-book ratio (P/B) is 3.08, slightly below the industry average of 3.09, ranking 83 out of 122 - The gross margin is 40.19%, lower than the industry average of 51.09%, ranking 84 out of 122 - The net margin is 6.8%, compared to the industry average of 10.86%, ranking 80 out of 122 - Return on equity (ROE) is 1.28%, ranking 59 out of 122 [2]